News - Page 3 of 6

Four Years of Connecting: The Farewell of Hubertus Irth, a Driving Force Behind PharmaNL

January 29, 2026

After nearly four years, Hubertus Irth is stepping down as a board member of PharmaNL, the national pharmaceutical programme made possible in part by funding from the Dutch National Growth Fund. As an academic and one of the programme’s founders, he played a key role in shaping the consortium, which brings together Leiden University / […]

Today’s input, tomorrow’s impact: PharmaNL Expert Event Human Capital Growth

January 27, 2026

Yesterday, PharmaNL’s Expert Event Human Capital Growth took place at the Jaarbeurs in Utrecht. The event offered participants a valuable platform to discuss priorities and challenges related to Human Capital in the pharmaceutical sector and to support the revision of the PharmaNL Investment Agenda. The programme opened with a warm welcome by Jon de Vlieger […]

Innovation in action: video National Growth Fund

December 9, 2025

What does PharmaNL actually stand for? In this short video, produced by the National Growth Fund, Board Member Ton Vries explains how we connect knowledge institutions, companies, and start-ups. This collaboration helps innovative medicines and production technologies move faster from idea to production. By investing in R&D infrastructure and training, we position the Netherlands as […]

Eight National Growth Fund initiatives join forces to strengthen the Dutch Life Sciences & Health ecosystem

December 4, 2025

Eight initiatives funded through the Dutch National Growth Fund are joining forces to accelerate Life Sciences & Health innovation and sustainable economic growth, with a focus on societal impact in The Netherlands. On December 2, representatives of Biotech Booster, Health-RI, HOLOmicrobiome, NXTGEN Hightech, Ombion, Oncode Accelerator, PharmaNL and RegMed XB officially signed a Memorandum of Understanding […]

Impact Series 6: ACESO. Innovation in screening infrastructure

November 27, 2025

The ACESO project is central in this sixth edition of the PharmaNL Impact Series. In this series, we spotlight a different project each time that, with the support of PharmaNL and made possible by ZonMw, contributes to the future of the Dutch pharmaceutical sector. What are the first results, what challenges are there, and what […]

Funded Projects in the Human Capital Growth 2024 Funding Round

October 30, 2025

Good news: six new projects have been awarded funding within the PharmaNL Human Capital Growth (HCG) program line. These projects specifically focus on developing flexible post-secondary, post-bachelor, and post-graduate education tailored to the evolving needs of the pharmaceutical sector. The PharmaNL Human Capital Growth 2024 call marks the second funding round within the HCG program […]

Impact Series Episode 5: Groningen Human Capital for Life Sciences. Training program gives professionals an edge in bioanalysis and gene technology

September 4, 2025

In the PharmaNL Impact Series, we show how innovative projects come to life thanks to PharmaNL funding: what first results have been achieved, what challenges arise, and what lessons they offer to others. In this fifth episode, the spotlight is on the Groningen Human Capital for Life Sciences project, led by the LIFE Cooperative together […]

Impact Series 4: Early Drug Discovery Education Track. Future-proof training for pharma professionals

July 7, 2025

“The pharmaceutical industry is evolving at lightning speed. If we don’t continuously upskill our professionals, they’ll fall behind, and that will negatively impact the entire sector.” With this clear message, Adinda Diekstra, Programme Manager for Post-Bachelor Courses & Training at HAN University of Applied Sciences, underscores the importance of the Early Drug Discovery Education Track […]

Impact Series 3: Nanoworx. Smart Optimization for Scale-Up Makes the Difference

June 25, 2025

In the PharmaNL Impact Series, we spotlight innovative projects that have taken off thanks to funding from PharmaNL. What are the initial results? What challenges have emerged? And what can others learn from these experiences? In this third episode, we take a closer look at Nanoworx, a promising initiative within the PharmaNL program line Shared […]

Impact Series 2: iPsomics. From Academic Innovation to Personalized Cancer Treatment

June 19, 2025

The PharmaNL Impact Series showcases real-life examples of how PharmaNL projects are progressing. What early results are emerging, what challenges are being faced, and what lessons can others take from them? In this second episode, we caught up with Peter Ketelaar and Floris Foijer of iPsomics, a promising life science start-up born out of the […]